Journal of Veterinary Behavior: Clinical Applications and Research
Volume 4, Issue 3 , Pages 118-126, May 2009

Use of memantine in treatment of canine compulsive disorders

  • Barbara M. Schneider, Dr. Med. Vet.

      Affiliations

    • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts
    • ,
  • Nicholas H. Dodman, BVMS

      Affiliations

    • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts
    • Corresponding Author InformationAddress for reprint requests and correspondence: Nicholas H. Dodman, BVMS, 200 Westborough Road, North Grafton, MA 01536; Phone: (508) 887-4665; Fax: (508) 839-8734
    • ,
  • Louise Maranda, DMZ MSc PhD

      Affiliations

    • Wildlife Medicine, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts

Abstract 

Medication plays an important role in the treatment of canine compulsive disorders (CCD). Not all cases can be managed with the current medications, and new pharmacological options are needed. This case series assesses the efficacy of the NMDA receptor blocker memantine as a possible new treatment option for CCD. Thirteen dogs with different manifestations of CCD were enrolled in the study, and data from 11 dogs were available for analysis. A behavioral and clinical history was obtained for each dog. Further medical tests were performed if deemed necessary.

The main presenting complaints in the included cases were light/shadow chasing, spinning/circling, and tail chasing. All dogs were either treated with memantine alone or memantine was added to ongoing fluoxetine treatment. All owners of dogs included in the study were provided with a specific behavior modification plan in addition to the pharmacological treatment. Memantine was administered orally twice a day at a starting dose of 0.3-0.5 mg/kg. The dose was increased over time if necessary, and side effects permitting, to a dose not higher than 1 mg/kg. The owners were asked to use a clinical global impression scale (CGI) on a daily basis to assess the severity of their dog's compulsive behaviors. This score was obtained daily for up to 4 consecutive weeks, and average weekly scores were calculated.

Seven (64%) of the dogs included in the study showed a reduction in the severity of CCD, with CGI scores reduced by the second week of treatment. Only 1 out of 11 dogs showed a side effect (increased frequency of urination) that was potentially related to the medication. The results suggest that memantine may be an effective, well-tolerated option for the treatment of CCD either as a sole treatment or as an add-on to fluoxetine. Further studies are needed to investigate the efficacy of memantine in the treatment of CCD.

Keywords: memantine, canine compulsive disorder, dog, NMDA receptor blocker, pharmacological treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 15.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1558-7878(08)00223-2

doi:10.1016/j.jveb.2008.10.008

Journal of Veterinary Behavior: Clinical Applications and Research
Volume 4, Issue 3 , Pages 118-126, May 2009

Article Tools

* Image Usage & Resolution